Dihydroergotamine

Unassigned

New Medicines

Migraine - acute treatment

Information

New formulation
Not Known
Satsuma Pharmaceuticals

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Serotonin receptor agonist
Migraine affects 18% of women and 6% of men [1].
Migraine - acute treatment
Intranasal